期刊文献+

国产复方α-酮酸片用于老年维持性血液透析20例的效果评价 被引量:2

Evaluation on Effects of Domestic Compound Alpha-Keto Acid for Nutritional Status in El-derly Patients with Maintenance Hemodialysis in 20 Cases
下载PDF
导出
摘要 目的观察国产复方α-酮酸(科罗迪)对改善老年维持性血液透析患者营养状况的有效性。方法选择20例老年维持性血液透析营养不良患者,在常规血液透析基础上,治疗组口服科罗迪片,每次4片、每日3次,总观察期6月。分别在治疗开始及6月时检测患者主观综合营养评估(SGA)、人体测量(BMI,TSF,MAC,MAMC,GST)、血清白蛋白(ALB)、C反应蛋白(CRP)、胆固醇(TC)、甘油三酯(TG)、血钙(Ca)、血磷(P)、甲状旁腺激素(PTH)水平。结果治疗前维持性血液透析患者的SGA、人体测量、ALB水平有显著升高(P<0.01),CRP水平有显著下降(P<0.05),PTH有降低趋势但无统计学意义(P>0.05),Kt/V、胆固醇、甘油三酯、血钙变化无统计学意义(P>0.05)。结论科罗迪可有效改善老年维持性血液透析患者的营养状况。 Objective To observe the effectiveness of domestic Compound Alpha-Keto Acid(KLD) in improving nutritional status in old pa- tients with maintenance hemodialysis, the effectiveness of, its related nutrition index,and other effects. Methods 20 patients with elderly mal- nutrition and maintenance hemodialysis were selected. On the basis of conventional hemodialysis,the treatment group received oral KLD,4 tablets each time,3 times a day,with a total observation period of 6 months. The subjective comprehensive nutrition evaluation(SGA),human body measurements(BMI, TSF, MAC, MAMC, GST), serum albumin(ALB), C -reactive protein(CRP), cholesterol(TC), triglyceride(TG), blood calcium(Ca),blood phosphorus(P) and parathyroid hormone(PTH) were detected at the beginning of treatment and in 6-month treatment respectively. Results SGA, human body measurements and ALB level after treatment in the patients with maintenance hemodialysis were significantly elevated(P 〈 0.01),the CRP level was significantly decreased(P 〈 0.05),PTH had the decreasing trend,but no statistical significance ( P 〉 0.05 ), Kt/V, cholesterol, triglycerides, blood calcium had no statistically significant differences ( P 〉 0.05). Conclusion KLD effectively improves the nutritional status in elderly patients with maintenance hemodialysis.
出处 《中国药业》 CAS 2013年第10期45-46,共2页 China Pharmaceuticals
关键词 国产复方α-酮酸片 老年 维持性血液透析 营养状况 KLD elderly patients maintenance hemodialysis nutritional status
  • 相关文献

参考文献3

二级参考文献30

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:135
  • 2王根荣,冯菡芳,侯积寿.含α-酮酸的复方氨基酸治疗慢性肾功能不全[J].新药与临床,1995,14(2):124-125. 被引量:7
  • 3郭志勇,袁伟杰,李保春,孙莉静,郭云珊,于蕾.α-酮酸配伍低蛋白饮食对长期腹膜透析患者营养状况影响的临床研究[J].中华肾脏病杂志,2006,22(7):435-437. 被引量:19
  • 4Moshyedi AK, Josephs MD, Abdalla EK, et al. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha. Infect Immun. 1998; 66(4) : 1800-1802.
  • 5Teplan V, Schtick O, Knotek A, et al. Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study. Ann Transplant. 2001; 6(1): 47-53.
  • 6Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999.55(2): 648-658.
  • 7Stenvinkel P, Heimbtirger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55(5): 1899-1911,
  • 8Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis. 2003 ; 42 : 295-302.
  • 9Kaizu Y, Kimura M, Yoneyama T, et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998. 31(1): 93-100.
  • 10Bergstrom J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial. 2000; 13 (3) : 163-175.

共引文献33

同被引文献32

  • 1邓英辉,林娜,王君梅,贾强.高通量血液透析对维持性血液透析患者钙磷代谢的长期影响[J].中华临床医师杂志(电子版),2011,5(18):5263-5266. 被引量:21
  • 2孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 3Martin-Navarro JA,Petkov-Stoyanov V,Guti6rrez-Sdnchez MJ. Efficacy of High Permeability Haemodialysis in Acute Renal Failure due to Vancomycin[J]. Nefrologia, 2014,34(5) : 688.
  • 4Rattanasompattikul, Molnar, Zaritsky, et al. Association of mal- nutrition-inflammation complex and responsiveness to erythro- poiesis-stimulating agents in long-term hemodialysis patients [J]. Nephrol Dial Transplant,2013,28(7):1936-1945.
  • 5Iiiima K. Hyperphosphatemia and cardiovascular diseases: im- pact of vascular calcification and endothelial dysfunction[J].. Clin Calcium,2012,22(10) :1505-1513.
  • 6Oluyombo R, Okunola OO, Olanrewaju TO, et al. Challenges of hemodialysis in a new renal care center:call for sustainability and improved outcome[J]. Int J Nephrol Renovasc Dis, 2014,18 (7) :347-352.
  • 7Mathew S, Tustison K S, Sugatani rT,et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD[J]. J Am Soc Nephrol,2008,19:1092.
  • 8Naves - Diaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus,PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study[J]. Nephrol Dial Transplant ,2011,26:1938.
  • 9KDIGO Clinical practice guideline for the diagnosis, e-valuation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney lnt,2009(Suppl):S1.
  • 10潘松球,黎琦.尿毒清对尿毒症血液透析患者钙磷代谢及甲状旁腺激素的影响[J].广西医学,2010,32(1):64-65. 被引量:8

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部